Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33,940,151
-
Total 13F shares
-
15,072,652
-
Share change
-
+111,855
-
Total reported value
-
$182,072,226
-
Price per share
-
$12.08
-
Number of holders
-
53
-
Value change
-
-$2,049,598
-
Number of buys
-
31
-
Number of sells
-
23
Institutional Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q1 2020
As of 31 Mar 2020,
TransMedics Group, Inc. - Common Stock (TMDX) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,072,652 shares.
The largest 10 holders included
ABRAMS CAPITAL MANAGEMENT, L.P., FMR LLC, CREDIT SUISSE AG/, BlackRock Inc., Sandhill Capital Partners LLC, VANGUARD GROUP INC, RTW INVESTMENTS, LP, FEDERATED HERMES, INC., Zimmer Partners, LP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
53
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.